🇨🇦 PF-06939999 in combination with docetaxel in Canada

PF-06939999 in combination with docetaxel (pf-06939999-in-combination-with-docetaxel) regulatory status in Canada.

Marketing authorisation

PF-06939999 in combination with docetaxel in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is PF-06939999 in combination with docetaxel approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for PF-06939999 in combination with docetaxel in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.